logo
        
 
 
 
 


Current TCR Studies


What type of study are you interested in?

Acne Study

Therapeutics Clinical Research is evaluating the safety and effectiveness of a new topical investigational medication for patients with acne. 

Inclusion Criteria

  • Males and females age 12 years and older
  • Facial acne, with at least 20 to a maximum of 75 pimples

Exclusion Criteria

  • Females who are pregnant, lactating or planning to become pregnant
  • More than 3 facial nodules/cysts
  • Facial hair that could interfere with study assessments
  • Use of certain acne medications or procedures

Text skin6 to 87888 or call (619) 512-DERM

Terms and Conditions of text message option:

  • TCR Acne Study: text skin6 to 87888 to receive more information about the study and to determine your eligibility.
  • Reply HELP for help. Reply STOP to cancel.  Message and Data rates may apply.
  • Privacy policy for the text message option can be found at: http://www.mobiletcs.com/87888privacy.htm 

Or take this brief survey

 

Healthy Volunteers

Therapeutics Clinical Research is evaluating the safety and effectiveness of a new investigational vaccine. 

We are looking for participants

  • Males and females aged 18-40 years
  • Healthy volunteers
  • Females who are NOT pregnant, lactating or planning to become pregnant
  • Without history or suspected history of any poxvirus-based vaccine

Qualified participants will receive

  • Trial-related examinations by a Board Certified Physician
  • Investigational vaccine or placebo
  • Compensation for time and travel

No insurance needed to participate.

If you are interested, please take this brief survey to pre-qualify:

Brief survey

 

Actinic Keratosis Study

Therapeutics Clinical Research is evaluating the safety and effectiveness of a topical investigational medication for people with actinic keratosis (AKs). 

We are looking for participants who:

  • Male or female  (not pregnant, lactating or planning to become pregnant)
  • 18 years or older
  • Have diagnosis of actinic keratosis on their face and scalp
  • Not currently using other therapies or presence of a medical condition that would interfere with participation in the study

Qualified participants may receive:

  • Study-related examinations by a Board Certified Physician
  • All study visits and study drug or placebo
  • Compensation for time and travel

If you are interested, call us or take this brief survey to see if you pre-qualify: https://www.research.net/s/AKNova

Confidentiality Maintained

No insurance required

 

Psoriasis Study Opportunities

Therapeutics Clinical Research is evaluating the safety and effectiveness of a new topical investigational medication for patients with plaque psoriasis. 

Inclusion Criteria

  • Males and females age 18 years and older
  • Clinical diagnosis of stable plaque psoriasis
  • If female, must not be pregnant

Exclusion Criteria

  • Spontaneously improving or rapidly deteriorating plaque psoriasis
  • Other non-plaque forms of psoriasis
  • Medications that may interfere with evaluation
  • Underlying disease that may interfere with evaluation

If this study interests you, please click here to take a brief survey

 

Therapeutics Clinical Research is conducting a medical research study evaluating a topical drug for patients with moderate to severe plaque psoriasis. 

We are looking for participants who are:

  • Male or female (not pregnant or breastfeeding)
  • 18 years of age or older with moderate to severe plaque psoriasis
  • In general good health

Qualified participants may receive:

  • Study-related skin examinations by a Board Certified Physician
  • All study visits and study drugs

If this study interests you, please click here to take a brief survey

 

 

619-512-DERM

 
   
D I R E C T I O N S
H I P A A
9025 Balboa Avenue, Suite 105, San Diego CA 92123
 
    T 858/571-6800 F 858/571-6801
 
   
Copyright © 2013, Therapeutics Clinical Research, all rights reserved